VIP VALUE IN PHARMACEUTICAL Trademark

Trademark Overview


On Tuesday, September 7, 1993, a trademark application was filed for VIP VALUE IN PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the VIP VALUE IN PHARMACEUTICAL trademark a serial number of 74432121. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, September 8, 1994. This trademark is owned by Valmed Pharmaceutical, Inc.. The VIP VALUE IN PHARMACEUTICAL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products
vip value in pharmaceutical

General Information


Serial Number74432121
Word MarkVIP VALUE IN PHARMACEUTICAL
Filing DateTuesday, September 7, 1993
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, September 8, 1994
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code8 - Abandoned
Class Status DateWednesday, August 4, 1999
Primary Code005
First Use Anywhere DateSaturday, March 1, 1986
First Use In Commerce DateSaturday, March 1, 1986

Trademark Owner History


Party NameValmed Pharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Island, NY 14072

Trademark Events


Event DateEvent Description
Thursday, September 8, 1994ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, January 12, 1994NON-FINAL ACTION MAILED
Wednesday, December 29, 1993ASSIGNED TO EXAMINER

Related Keywords


pharmaceutical value products